BDS PK Class 3

Embed Size (px)

Citation preview

  • 8/11/2019 BDS PK Class 3

    1/24

    General

    Pharmacology

    Elimination

    Dr.U.P.RathnakarMD.DIH.PGDHM

  • 8/11/2019 BDS PK Class 3

    2/24

    Microsomal Enzyme induction

    Drug A Metabolism[24hrs]Enzyme

    Drug B

    [Inducer]

    Enzyme+Enzyme+Enzyme+Enzyme Metabolism[6hrs]

    Effect

    =No drug effect

    OCP Metabolism[24hrs]Enzyme

    Drug B

    [Rifampicin]

    Enzyme+Enzyme+Enzyme+Enzyme Metabolism[6hrs]

    Prevents pregnancy

    =Pregnancy!

    +

    +

  • 8/11/2019 BDS PK Class 3

    3/24

    Microsomal Enzyme inhibition

    Drug A

    [Toxic]

    Metabolism[24hrs]Enzyme

    Drug B[Inhibitor]

    Metabolism[72hrs]

    Effect

    =Drug accumulates

    Warfarin Metabolism[24hrs]Enzyme

    Drug B

    [Erythrymycin]

    Enzyme Metabolism[72hrs]

    Anticogulant

    =Bleeding

    +

    +

    Enzyme

    Drug A

    [Toxicity]

    Warfarin

    [Toxicity]

  • 8/11/2019 BDS PK Class 3

    4/24

    Non-microsomal enzymes

    Genetic polymorphism

    INH Long duration of action=Lower doseNon-microsomal Enzyme

    Slow acetylators

    [40% of polpulation]

    INH Short duration of action=Higher doseNon-microsomal Enzyme

    Fast acetylators[40% of polpulation]

  • 8/11/2019 BDS PK Class 3

    5/24

    Factors affecting Biotransformation1. Age-Extremes of age enzymes may be

    deficient

    Eg.Chloramphenicol in prematurebabies causes Gray baby syndrome.

    2. Malnutrition:- metabolism due to enz.

    proteins.3. Liver disease:- metabolism-- so..dose

    of drug

    4. Genetic: Genetically determined variation inmetabolism

    Slow and fast acetylators-INH SCH

  • 8/11/2019 BDS PK Class 3

    6/24

    Prodrug

    Inactive drug

    Converted to active form by metabolism Improved B.A.-L-Dopa and Dopamine

    Prolongs duration of action- Fluphenazine

    Improves taste- Clindamycin palmitate Reduces ADE-Bacampicillin

    Methenamine release Formaldehyde inacidic urine

  • 8/11/2019 BDS PK Class 3

    7/24

    Drug ExcretionRemoval of drug and its metabolites

    from body Kidney

    Lungs

    Bile Feces

    Sweat

    Saliva

    Tears

    Milk

  • 8/11/2019 BDS PK Class 3

    8/24

  • 8/11/2019 BDS PK Class 3

    9/24

    Excretion-Kidney

    Renal

    excretion

    Glomerular

    Filtration

    Tubular

    secretion

    Tubular

    reabsorption

  • 8/11/2019 BDS PK Class 3

    10/24

    Glomerular Filtration

    Mol.size Depends on Renal blood

    flow Plasma protein binding

  • 8/11/2019 BDS PK Class 3

    11/24

    Tubular secretion-Active

    Carrier mediated

    Not affected by PPB Penicillin, Probenecid, Quinine

    May use same carrier-Non-specific

  • 8/11/2019 BDS PK Class 3

    12/24

    Tubular Reabsorption-Passive

    Depends on pH and ionization

    Strongly acidic and alkaline-Unionized-

    Excreted Weakly acidic-Ionized in alkaline

    medium-not absorbed. Eg. Alkaline urineand aspirin toxicity

    Weakly basic-Ionized in acidic urine

    Eg. Acidification of urine NH4cl or Vit-

    C-in Amphetamine poisoning

  • 8/11/2019 BDS PK Class 3

    13/24

    Factors affecting renal excretion

  • 8/11/2019 BDS PK Class 3

    14/24

    Excretion-Other routes Lungs: Alcohol, G.A,

    Faeces: Drugs not absorbed and secretedwith bile

    Bile:Excreted in BileReabsorbed from

    small intestine-This cycle is E.H.circulationEg.E.Mycin

    Skin: As and Hg

    Saliva: KI, phenytoin. Li Milk:Milk acidicAlkaline drugs ionized

    and accumulate. Eg. TetracyclineADE in

    infant

  • 8/11/2019 BDS PK Class 3

    15/24

  • 8/11/2019 BDS PK Class 3

    16/24

  • 8/11/2019 BDS PK Class 3

    17/24

  • 8/11/2019 BDS PK Class 3

    18/24

    First order

    Zero order

  • 8/11/2019 BDS PK Class 3

    19/24

    PLASMA HALF LIFE- t1/2

    It is the time required for the plasmaconc. of the drug to be reduced to half ofits original value.

  • 8/11/2019 BDS PK Class 3

    20/24

    100

    50

    150

    75

    175

    87.5

    187.5

    93.5

    193.5

    96.5

    196.5

    98

    198

    99

    199

    100

    Takes 4-5 halflives to reach steady state concn.

    Steady state[Plataeu principle]

  • 8/11/2019 BDS PK Class 3

    21/24

    Clinical Importance of Half Life

    t helps to determine theduration of action of the

    drug.

    To determine the frequencyof drug administration.

    To determine the time takento achieve the steady state.

  • 8/11/2019 BDS PK Class 3

    22/24

    Elimination First order

    100 mg administered[100%]

    1 t1/2 50mg 50%

    2 t1/2 25mg 75% 3t1/2 12.5 mg 87.5%

    4t1/2 6.25.mg 93.75%

    Take 4-5 halflives for completeelimination of a drug

  • 8/11/2019 BDS PK Class 3

    23/24

    Therapeutic drug monitoring-TDM Monitoring drug therapy by measuring plasma

    conc.of drugs. Indications

    1. Drugs with low margin of safety-Digoxin,Lithium

    2. To check Pt. compliance.3. If individual variations are large.- TCA.

    4. Potentially toxic drugs used in presence of

    renal failure-AMINOGYCOSIDES5. When Pt. does not respond without reason

  • 8/11/2019 BDS PK Class 3

    24/24

    How to prolong duration of action of a

    drug?

    Prolong absorption from site of administration

    Oral- SR tablets, CR. ?Eg

    Parenteral: Less soluble form, oily prep,

    adrenaline

    TTS ?Eg

    Increase PPB ?Eg

    Slow down Metabolism ?Eg

    Reduce Renal Excretion ?Eg